SEC ownership of CareDx, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001217234.

Comparable stake leader

BlackRock, Inc.

Disclosed value leader

BlackRock, Inc.

Comparable rows

50/50

Latest evidence

05 Aug 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
BlackRock, Inc.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
05 Aug 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001217234
Issuer location
Brisbane, CA

Ownership snapshot

Top shareholders of CareDx, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
05 Aug 2026
13F 13D/G 3/4/5 Lead comparable stake: 9% 13D/G row: BlackRock, Inc. Showing 1-8 of 50 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 9%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 9%
STATE STREET CORP 4.8%
ARK Investment Management LLC 4.5%
GAGNON SECURITIES LLC 4.4%
BAMCO INC /NY/ 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13F 13D/G
Company
9%
from 13D/G
$137,219,211
4,814,709 shares
30 Jun 2026
STATE STREET CORP
13D/G 13F
STATE STREET CORPORATION · Company
4.8%
$70,387,142
2,468,858 shares
-$7,666,168 30 Jun 2026
ARK Investment Management LLC
13F 13D/G
Company
4.5%
from 13D/G
$55,675,622
1,953,531 shares
30 Jun 2026
GAGNON SECURITIES LLC
13D/G 13F
Neil Gagnon · Company
4.4%
$65,386,659
2,293,464 shares
-$21,709,852 31 Jul 2026
BAMCO INC /NY/
13D/G 13F
Baron Capital Group, Inc. · Company
3.8%
$55,233,164
1,937,326 shares
-$34,721,018 30 Jun 2026
Abhishek Jain
3/4/5
Chief Financial Officer
0.62%
$3,907,039
319,725 shares
01 Aug 2025
Keith Kennedy
3/4/5
CFO & COO
0.43%
$3,817,880
219,924 shares
01 Jul 2026
Jessica Meng
3/4/5
Chief Commercial Officer
0.33%
$2,921,462
168,287 shares
01 Jul 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$13,308,479.

Buys
$0
Insiders: 0
Sells
$13,308,479
Insiders: 7
Net
-$13,308,479
Shares: -394,384
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 394,384
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 326,786 $0 $11,922,227 -$11,922,227
3-6 0 23,540 $0 $487,412 -$487,412
6-9 0 41,370 $0 $857,117 -$857,117
9-12 0 2,688 $0 $41,723 -$41,723

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 23 reporting-owner rows connected to CareDx, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
23
Largest Forms 3/4/5 holder
John Walter Hanna Jr.
Net 12M change
-$13,308,480
Latest report
05 Aug 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
John Walter Hanna Jr. President and CEO, Director $25,493,424 -$7,540,919 -23% Filing P/S 16 Jul 2026
Alexander L. Johnson President of Patient and Testing Services $9,284,746 Filing P/S 20 Aug 2024
George Bickerstaff Director $6,205,013 -$925,700 -13% Filing P/S 05 Aug 2026
Abraham Ronai Officer $6,160,873 Mixed 20 Sep 2023
Peter Maag Director $5,745,904 Mixed 07 Jul 2025
Reginald Seeto President and Chief Executive Officer, Director $5,721,218 Mixed 02 Oct 2023
Michael Goldberg Director $5,500,054 -$2,103,497 -28% Mixed 04 Aug 2026
Jeffrey Adam Novack Secretary and General Counsel $4,959,006 -$452,744 -8.4% Filing P/S 05 Aug 2026
Abhishek Jain Chief Financial Officer $3,907,039 Mixed 01 Aug 2025
Keith Kennedy Cfo & Coo $3,817,880 Mixed 01 Jul 2026
Fred E. Cohen Director $2,950,014 Mixed 12 Jun 2026
Jessica Meng Chief Commercial Officer $2,921,462 Mixed 01 Jul 2026
Christine Cournoyer Director $2,100,137 -$750,973 -26% Mixed 04 Aug 2026
Sasha King Chief Marketing Officer $1,697,173 Mixed 09 Aug 2022
Nathan Smith Chief Financial Officer $1,613,506 Mixed 02 Feb 2026
Hannah Valantine Director $1,340,873 -$1,319,971 -50% Filing P/S 16 Jul 2026
William A. Hagstrom Director $1,158,857 Mixed 11 Jun 2025
Arthur A. Torres Director $853,685 -$214,676 -20% Mixed 14 May 2026
Richard Bryan Riggsbee Director $767,029 Mixed 12 Jun 2026
Ralph Snyderman Director $694,633 Mixed 04 Oct 2022

Recent insider transactions for CareDx, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Jeffrey Adam Novack CDNA Common Stock Sale -2.47% $124,349 $46.26 -2,688 106,075 05 Aug 2026 Direct
George Bickerstaff CDNA Common Stock Sale -13% $925,700 $46.28 -20,000 134,061 05 Aug 2026 Direct
Michael Goldberg CDNA Common Stock Sale -42% $2,103,497 $47.06 -44,700 61,738 04 Aug 2026 Direct
Christine Cournoyer CDNA Common Stock Sale -27.1% $750,973 $46.94 -16,000 42,943 04 Aug 2026 Direct
Jeffrey Adam Novack CDNA Common Stock Tax liability -2.57% -2,872 108,763 01 Aug 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -15.3% $4,458,637 $37.79 -118,000 653,448 16 Jul 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Options Exercise 18.1% 118,000 771,448 16 Jul 2026 Direct
John Walter Hanna Jr. CDNA Employee Stock Option (Right to Buy) Options Exercise -18.7% -118,000 512,706 16 Jul 2026 Direct
Hannah Valantine CDNA Common Stock Sale -44% $1,040,243 $36.15 -28,779 36,686 16 Jul 2026 Direct
Hannah Valantine CDNA Common Stock Options Exercise 78.4% 28,779 65,465 16 Jul 2026 Direct
Hannah Valantine CDNA Stock Option (Right to Buy) Options Exercise -100% -28,779 0 16 Jul 2026 Direct
Michael Goldberg CDNA Common Stock Award 1.67% 1,746 106,438 02 Jul 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Tax liability -1.29% -8,511 653,448 01 Jul 2026 Direct
Jeffrey Adam Novack CDNA Common Stock Tax liability -0.89% -997 111,635 01 Jul 2026 Direct
Jessica Meng CDNA Common Stock Tax liability -1.41% -2,411 168,287 01 Jul 2026 Direct
Keith Kennedy CDNA Common Stock Tax liability -1.31% -2,930 219,924 01 Jul 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -5.68% $1,166,836 $29.24 -39,900 661,959 29 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Options Exercise 6.03% 39,900 701,859 29 Jun 2026 Direct
John Walter Hanna Jr. CDNA Employee Stock Option (right to buy) Options Exercise -5.95% -39,900 630,706 29 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -0.02% $2,900 $29.00 -100 661,959 26 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Options Exercise 0.02% 100 662,059 26 Jun 2026 Direct
John Walter Hanna Jr. CDNA Employee Stock Option (right to buy) Options Exercise -0.01% -100 670,606 26 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Options Exercise 2.43% 15,676 661,959 15 Jun 2026 Direct
John Walter Hanna Jr. CDNA Employee Stock Option (right to buy) Options Exercise -2.28% -15,676 670,706 15 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -2.72% $424,877 $24.03 -17,683 631,959 15 Jun 2026 Direct
Hannah Valantine CDNA Common Stock Sale -24.8% $279,728 $23.11 -12,103 36,686 15 Jun 2026 Direct
Hannah Valantine CDNA Common Stock Award 25.1% 9,795 48,789 12 Jun 2026 Direct
Christine Cournoyer CDNA Common Stock Award 19.9% 9,795 58,943 12 Jun 2026 Direct
Richard Bryan Riggsbee CDNA Common Stock Award 33.2% 9,795 39,312 12 Jun 2026 Direct
Fred E. Cohen CDNA Common Stock Award 6.31% 9,795 165,060 12 Jun 2026 Direct
Suresh Gunasekaran CDNA Common Stock Award 35.7% 9,795 37,248 12 Jun 2026 Direct
George Bickerstaff CDNA Common Stock Award 6.79% 9,795 154,061 12 Jun 2026 Direct
Michael Goldberg CDNA Common Stock Award 5.27% 9,795 195,737 12 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Options Exercise 2.15% 13,618 646,283 11 Jun 2026 Direct
John Walter Hanna Jr. CDNA Employee Stock Option (right to buy) Options Exercise -1.95% -13,618 686,382 11 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -3.28% $528,443 $24.02 -21,998 649,642 11 Jun 2026 Direct
Jeffrey Adam Novack CDNA Common Stock Tax liability -1.13% -1,292 112,632 06 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Options Exercise 0.11% 706 632,665 04 Jun 2026 Direct
John Walter Hanna Jr. CDNA Employee Stock Option (right to buy) Options Exercise -0.1% -706 700,000 04 Jun 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -0.71% $116,045 $24.00 -4,835 671,640 04 Jun 2026 Direct
Arthur A. Torres CDNA Common Stock Sale -14.4% $128,978 $19.89 -6,484 38,665 15 May 2026 Direct
Arthur A. Torres CDNA Common Stock Sale -8.3% $85,698 $20.97 -4,086 45,149 14 May 2026 Direct
Jeffrey Adam Novack CDNA Common Stock Sale -2.31% $55,581 $20.68 -2,688 113,924 05 May 2026 Direct
Jeffrey Adam Novack CDNA Common Stock Tax liability -2.4% -2,873 116,612 01 May 2026 Direct
Keith Kennedy CDNA Common Stock Award 12.2% 24,134 221,548 20 Apr 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Sale -1.5% $217,156 $21.12 -10,282 676,475 16 Apr 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Tax liability -8.29% -62,049 686,757 15 Apr 2026 Direct
Jeffrey Adam Novack CDNA Common Stock Tax liability -1.56% -1,892 119,485 06 Apr 2026 Direct
Michael Goldberg CDNA Common Stock Award 1.08% 1,981 185,942 02 Apr 2026 Direct
John Walter Hanna Jr. CDNA Common Stock Tax liability -4.47% -35,037 748,806 01 Apr 2026 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .